全程仅需一次静脉注射，微型脑机接口新技术展现应用前景

Core Insights - A new brain-machine interface chip thinner than a human hair has been developed, showing potential for treating neurological diseases such as Parkinson's and epilepsy, and opening new avenues in biomedical engineering [1][2] Group 1: Technology Development - The MIT Media Lab team has created a brain-machine interface chip using a novel organic semiconductor material, which is attached to immune cells and delivered via intravenous injection [2] - This technology allows for non-invasive implantation of the device into the brain, overcoming the limitations of current invasive methods that require surgical procedures [1][2] Group 2: Clinical Application and Market Potential - The research is in the early stages of transitioning from basic research to clinical application, with successful in vivo experiments conducted on live animals [1][2] - The recent approval of a wireless implanted brain-machine interface system by Shanghai Ladder Medical Technology Co., Ltd. marks a significant step for invasive brain-machine interface technology in China, facilitating faster market entry [2][3] Group 3: Future Implications - The brain-machine interface technology has the potential to significantly benefit patients with paralysis, speech impairments, and other neurological disorders, possibly enabling quicker recovery for those who have lost consciousness [3] - Collaboration across multiple disciplines, including materials science, artificial intelligence, and medicine, is essential for the advancement of brain-machine interface technology [3]